Press Releases

All Releases
View Summary Five Prime Therapeutics to Announce First Quarter 2015 Financial Results and Host Conference Call on May 13
Thursday, May 7, 2015
PDF 12.9 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present at the Credit Suisse Antibody Day
Friday, May 1, 2015
PDF 6.7 KB Add to Briefcase
View Summary Five Prime Therapeutics to Host Research & Development Day on May 5, 2015
Wednesday, April 22, 2015
PDF 8.4 KB Add to Briefcase
View Summary Five Prime Therapeutics Announces Fourth Quarter and Full Year 2014 Financial Results
Tuesday, March 17, 2015
PDF 19.0 KB Add to Briefcase
View Summary Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2014 Financial Results and Host Conference Call on March 17
Tuesday, March 10, 2015
PDF 6.4 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present at the Barclays Global Healthcare Conference
Thursday, March 5, 2015
PDF 6.6 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present at the RBC Capital Markets 2015 Healthcare Conference
Wednesday, February 18, 2015
PDF 6.2 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present at the 2015 Leerink Global Healthcare Conference
Wednesday, February 4, 2015
PDF 6.6 KB Add to Briefcase
View Summary Five Prime Therapeutics Announces Closing of Public Offering
Monday, January 12, 2015
PDF 14.4 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Thursday, January 8, 2015
PDF 6.3 KB Add to Briefcase
View Summary Five Prime Therapeutics Prices Public Offering of Common Stock
Tuesday, January 6, 2015
PDF 6.3 KB Add to Briefcase
View Summary Five Prime Announces $75 Million Proposed Public Offering of Common Stock
Monday, January 5, 2015
PDF 8.1 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference
Thursday, December 4, 2014
PDF 13.2 KB Add to Briefcase
View Summary Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Clinical Trial Evaluating FPA144 in Gastric Cancer
Thursday, December 4, 2014
PDF 8.7 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present at The 26th Annual Piper Jaffray Healthcare Conference
Tuesday, November 25, 2014
PDF 13.5 KB Add to Briefcase
View Summary Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types
Monday, November 24, 2014
PDF 17.1 KB Add to Briefcase
View Summary Five Prime Therapeutics Initiates Dosing of Rheumatoid Arthritis Patients in Its Phase 1 Clinical Trial of FPA008
Monday, November 17, 2014
PDF 16.1 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present Data From Healthy Volunteer Cohorts in Phase 1 Trial of FPA008 at the 2014 ACR/ARHP Annual Scientific Meeting
Thursday, November 13, 2014
PDF 11.8 KB Add to Briefcase
View Summary Five Prime Therapeutics Announces Third Quarter 2014 Financial Results
Monday, November 10, 2014
PDF 17.1 KB Add to Briefcase
View Summary Five Prime Therapeutics Announces Presentation at the 2014 Society for Immunotherapy of Cancer Annual Meeting
Wednesday, November 5, 2014
PDF 8.7 KB Add to Briefcase
Showing 81-100 of 168 Page: 1 2 3 4 5 6 7 8 9  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

FPRX (Common Stock)

Exchange
NASDAQ
Price
28.95
Change (%)
0.00
Volume
N/A

Data as of 4:00 PM ET on Friday, May 26, 2017
Minimum 20 minute delay
Refresh quote
Powered By eSignal, Inc.